Taru Muranen,
Assistant Professor of Medicine,
Beth Israel Deaconess Medical Center and Harvard Medical School
Dr. Muranen’s lab focuses on studying how tumor stroma, and more specifically extracellular matrix proteins contribute to tumor growth and drug resistance in breast and pancreatic cancers. Dr. Muranen got her PhD in the University of Helsinki, Finland, completed her postdoctoral training at Harvard Medical School with Dr. Joan Brugge, and started her own laboratory in Beth Israel Deaconess Medical Center in late 2016.
|
|
|
Add to Calendar ▼2022-03-22 14:30:002022-03-22 15:30:00Europe/LondonNovel Organoid Models for the Study of Hormone Positive Breast CancerClinical Translation of Organoids and Organs-on-Chips 2022 in BostonBostonSELECTBIOenquiries@selectbiosciences.com
